X4 Pharmaceuticals (XFOR) went public on November 16, 2017, when it opened at a split-adjusted price of $2,340.00.
| DATE | OPEN | HIGH | LOW | CLOSE | VOLUME |
|---|---|---|---|---|---|
January 2026 | $4.08 | $4.08 | $3.74 | $4.00 | 1,275,700 |
December 2025 | $3.64 | $4.56 | $3.05 | $4.00 | 19,710,410 |
November 2025 | $4.03 | $4.15 | $3.26 | $3.64 | 10,094,300 |
October 2025 | $3.40 | $4.54 | $2.80 | $4.04 | 33,979,500 |
September 2025 | $3.65 | $3.79 | $2.88 | $3.42 | 10,982,000 |
August 2025 | $1.58 | $4.83 | $1.35 | $3.76 | 212,875,300 |
July 2025 | $1.93 | $2.25 | $1.38 | $1.68 | 38,118,600 |
June 2025 | $3.55 | $4.48 | $1.81 | $1.90 | 8,878,300 |
May 2025 | $4.12 | $4.25 | $2.67 | $3.40 | 3,867,300 |
April 2025 | $6.99 | $7.44 | $3.83 | $4.31 | 2,122,369 |
March 2025 | $12.24 | $12.54 | $6.78 | $7.08 | 1,184,197 |
February 2025 | $19.50 | $20.10 | $10.83 | $11.85 | 1,211,266 |
January 2025 | $22.05 | $24.45 | $12.75 | $21.00 | 4,784,708 |
December 2024 | $11.82 | $26.82 | $10.56 | $22.02 | 2,603,238 |
November 2024 | $15.06 | $20.40 | $7.83 | $11.79 | 3,536,745 |
October 2024 | $19.92 | $20.34 | $14.16 | $15.00 | 1,048,819 |
September 2024 | $21.00 | $22.20 | $18.30 | $20.07 | 479,846 |
August 2024 | $23.40 | $24.57 | $17.46 | $21.00 | 843,252 |
July 2024 | $18.27 | $26.97 | $15.93 | $24.00 | 1,565,889 |
June 2024 | $30.00 | $33.90 | $17.10 | $17.40 | 1,817,877 |
May 2024 | $33.90 | $36.00 | $25.80 | $30.30 | 1,634,613 |
April 2024 | $42.60 | $48.00 | $27.00 | $33.60 | 3,047,216 |
March 2024 | $29.28 | $48.00 | $24.60 | $41.70 | 2,338,155 |
February 2024 | $23.58 | $32.10 | $23.13 | $29.13 | 925,210 |
January 2024 | $25.53 | $27.48 | $21.00 | $23.43 | 837,163 |
